Hurley Capital’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Hurley Capital’s Portfolio IBDQ Stock Details IBDQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-83,016	Closed	-$2.09M	–	673
2025 Q3	$2.09M	Sell	83,016 -2,388	-3%	-$60K	1.18%	22
2025 Q2	$2.15M	Sell	85,404 -536	-0.6%	-$13.5K	1.51%	16
2025 Q1	$2.16M	Buy	85,940 +2,217	+3%	+$55.7K	1.64%	15
2024 Q4	$2.1M	Buy	+83,723	New	+$2.1M	1.69%	16

Other funds holding IBDQ

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

Balentine LLC Atlanta, Georgia $2.48B AUM 17.44% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Hurley Capital's IBDQ Position: Q4 2025 in Review

Hurley Capital sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 83,016 shares — an estimated $2.09M sold.

Hurley Capital first reported a position in IBDQ in Q4 2024 and held it in 4 quarters. The position peaked at $2.16M in Q1 2025. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

Hurley Capital reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
Hurley Capital sold 83,016 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $2.09M.
Hurley Capital first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q4 2024 and held it in 4 quarters.
Hurley Capital's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $2.16M in Q1 2025.
3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on Hurley Capital's 13F filing for Q4 2025, filed 17 Feb 2026.